Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > EBITDA

Adverum Biotechnlgs EBITDA Chart (ADVM)

Adverum Biotechnlgs annual/quarterly EBITDA from 2013 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Adverum Biotechnlgs EBITDA for the quarter ending June 06, 2020 was $-28m a 41.32% decrease of -12m year over year
  • Adverum Biotechnlgs EBITDA for the last 12 months ending June 06, 2020 was $-88m a 33.57% decrease of -29m year over year
  • Adverum Biotechnlgs Annual EBITDA for 2019 was $-67m a -6.51% increase of 4m from 2018
  • Adverum Biotechnlgs Annual EBITDA for 2018 was $-71m a 21.84% decrease of -16m from 2017
  • Adverum Biotechnlgs Annual EBITDA for 2017 was $-56m a 14.68% decrease of -8m from 2016
Other Income Statement Metrics:
  • Adverum Biotechnlgs Net Income for the quarter ending December 12, 2018 was $-16m a -9.84% increase of 2m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM EBITDA Data

06/2020$-28m
03/2020$-23m
12/2019$-19m
09/2019$-17m
06/2019$-16m
03/2019$-15m
12/2018$-16m
09/2018$-18m
06/2018$-19m
03/2018$-17m

Annual ADVM EBITDA Data

2019$-67m
2018$-71m
2017$-56m
2016$-48m
2015$-42m
2014$-24m
2013$-3m
2012$-2m